Zobrazeno 1 - 10
of 531
pro vyhledávání: '"immune profile"'
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract Mycobacterium avium complex pulmonary disease (MAC-PD) has a heterogeneous clinical course. However, immune profiles associated with MAC-PD clinical course are limited. We performed single-cell RNA sequencing of peripheral blood mononuclear
Externí odkaz:
https://doaj.org/article/438eb0385d2644519ad173fb5991d7de
Autor:
О.V. Dolgikh, N.А. Nikonoshina
Publikováno v:
Analiz Riska Zdorovʹû, Iss 1, Pp 150-157 (2024)
Examining peculiarities of an immune profile and genetic polymorphisms is especially relevant when identifying markers of effect and sensitivity to exposure to benzo(a)pyrene in northern areas. We examined 1253 children who lived in industrial cente
Externí odkaz:
https://doaj.org/article/59a7706233af4e29a964b4aba8068845
Autor:
Li Jia, Na Li, Vincent van Unen, Jaap-Jan Zwaginga, Jerry Braun, Pieter S. Hiemstra, Frits Koning, P. Padmini S. J. Khedoe, Jan Stolk
Publikováno v:
Cells, Vol 13, Iss 19, p 1636 (2024)
Emphysema in patients with chronic obstructive pulmonary disease (COPD) is characterized by progressive inflammation. Preclinical studies suggest that lung volume reduction surgery (LVRS) and mesenchymal stromal cell (MSC) treatment dampen inflammati
Externí odkaz:
https://doaj.org/article/3b7d1e31afbb46d1b586ba30900fd01f
Autor:
Cristina López, Nathalie Depreux, Isabel Bielsa, Albert Roger, Bibiana Quirant-Sanchez, Maria Basagaña, Yanina Jurgens, Clara Padró, Sira Miquel, Eva Martinez-Caceres, Aina Teniente-Serra
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundChronic spontaneous urticaria (CSU) is a highly prevalent and difficult to manage cutaneous disease characterized by the presence of recurrent urticaria, angioedema, or both, for a period of 6 weeks or longer. One of the biological treatmen
Externí odkaz:
https://doaj.org/article/9d988bfbb70b4a6495d0ba11e1dc458d
Autor:
Takahiro Tsujikawa, Kazuchika Ohno, Kei-ichi Morita, Sumiyo Saburi, Junichi Mitsuda, Kanako Yoshimura, Alisa Kimura, Hiroki Morimoto, Hiroshi Ogi, Saya Shibata, Takumi Akashi, Morito Kurata, Issei Imoto, Yasushi Shimizu, Satoshi Kano, Akihito Watanabe, Tomoko Yamazaki, Yukinori Asada, Ryuichi Hayashi, Yuki Saito, Hiroyuki Ozawa, Kiyoaki Tsukahara, Nobuhiko Oridate, Daisuke Sano, Arata Horii, Yushi Ueki, Takashi Maruo, Nobuaki Mukoyama, Nobuhiro Hanai, Takahito Fukusumi, Hiroshi Iwai, Takuo Fujisawa, Takashi Fujii, Ken-ichi Nibu, Shigemichi Iwae, Tsutomu Ueda, Nobuyuki Chikuie, Ryuji Yasumatsu, Mioko Matsuo, Hirohito Umeno, Takeharu Ono, Muneyuki Masuda, Satoshi Toh, Kyoko Itoh, Shigeru Hirano, Takahiro Asakage
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundIn view of improving biomarkers predicting the efficacy of immunotherapy for head and neck squamous cell carcinoma (R/M HNSCC), this multicenter retrospective study aimed to identify clinical, tumor microenvironmental, and genomic factors t
Externí odkaz:
https://doaj.org/article/b5c525023e134051b6b1b1fa136b47f3
Autor:
Kxitiza Pandey, Sulekha Nautiyal, Arun Pandey, Geetika Rana, Himansha Pandey, Vijay Kumar Kataria
Publikováno v:
National Journal of Laboratory Medicine, Vol 13, Iss 01, Pp 37-41 (2024)
Introduction: Autoimmunity is a condition characterised by a specific humoral or cell-mediated immune response against constituents of the body’s own tissues. The diagnosis of Autoimmune Diseases (AD) is based on clinical presentation, laboratory d
Externí odkaz:
https://doaj.org/article/166d28e9c77e43aa9f44259c8140a4a2
Autor:
Valentina Rubino, Flavia Carriero, Anna Teresa Palatucci, Angela Giovazzino, Fabrizio Salemi, Rosa Carrano, Massimo Sabbatini, Giuseppina Ruggiero, Giuseppe Terrazzano
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 19, p 10610 (2024)
Identification of early signatures of immune rejection represents a key challenge in the clinical management of kidney transplant. To address such an issue, we enrolled 53 kidney transplant recipients without signs of graft rejection, no infectious e
Externí odkaz:
https://doaj.org/article/a095844c058a47d78f43d5c27a956be1
Autor:
Ayelén Ivana Pesce Viglietti, María Belén Bordignon, Alexis Ostinelli, Manglio Miguel Rizzo, Gerardo Cueto, María Belén Sanchez, Florencia Perazzo, Mora Amat, Federico Coló, María Victoria Costanzo, Adrián Nervo, Jorge Nadal, Gabriel Crimi, Ignacio Mc Lean, Eunice Amancay Spengler, José Mordoh, Pablo Mandó, Estrella Mariel Levy
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 17, p 9268 (2024)
Currently, therapy for early-stage human epidermal growth factor receptor 2-positive (HER2+) breast cancer (BC) is based on the combination of trastuzumab and pertuzumab plus chemotherapy in a neoadjuvant regimen. The INMUNOHER study aimed to detect
Externí odkaz:
https://doaj.org/article/d6c1e774ca4b49c8941b609b2ef344a6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Cancer Medicine, Vol 12, Iss 14, Pp 15304-15316 (2023)
Abstract Background Homologous recombination (HR) repair (HRR) has been indicated to be a biomarker for immunotherapy, chemotherapy, and poly‐ADP ribose polymerase inhibitors inhibitors (PARPis). Nonetheless, their molecular correlates in upper tra
Externí odkaz:
https://doaj.org/article/4eba41e4371648e59005c4703f52dc81